Charles River Laboratories | Les Charges D'Exploitation



Operating Expenses Changement Date
Agilent USD 1.31B 12M 2025-01
Align Technology USD 848.16M 2.91M 2025-03
Bio-Rad Laboratories USD 561.7M 47.4M 2025-03
Bruker USD 915.5M 119.2M 2024-12
Cardinal Health USD 54.15B 567M 2025-03
Charles River Laboratories USD 1.17B 277.88M 2024-12
Cigna USD 63.49B 144M 2025-03
CVS Health USD 91.21B 3.64B 2025-03
Danaher USD 4.46B 655M 2025-03
Dentsply International USD 1.41B 1000K 2024-12
Elevance Health USD 46.09B 1.6B 2025-03
Galapagos EUR 233.68M 95.46M 2025-03
Hologic USD 1.01B 220.3M 2025-03
Humana USD 30.1B 342M 2025-03
Illumina USD 929M 590M 2024-12
Incyte USD 847.73M 29.46M 2025-03
IQVIA Holdings USD 3.33B 14M 2024-12
Laboratory Of America USD 3.01B 100.2M 2025-03
Lonza CHF 2.52B 776M 2024-06
McKesson USD 94.07B 997M 2024-12
Merck EUR 4.22B 52M 2024-12
Mettler Toledo International USD 681.8M 48.78M 2025-03
Novartis USD 11.28B 1.73B 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Quest Diagnostics USD 2.31B 46M 2025-03
Revvity USD 592.53M 18.09M 2025-03
Thermo Fisher Scientific USD 8.65B 731M 2025-03
United Therapeutics USD 411.6M 33.4M 2025-03
UnitedHealth USD 100.47B 7.46B 2025-03
Walgreens Boots Alliance USD 43.8B 4.12B 2025-02
Waters USD 580.45M 51.28M 2024-12
West Pharmaceutical Services USD 591M 1.8M 2025-03



Charles River Laboratories Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.